Article Per Year (5 Year)
p-Index From 2019 - 2024
0.408
P-Index
This Author published in this journals
All Journal Althea Medical Journal Ophthalmologica Indonesiana
Maula Rifada
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Success Rate of Trabeculectomy in Primary Glaucoma at Cicendo Eye Hospital on January–December 2013 Erva Monica Saputro; Maula Rifada; RB. Soeherman Herdiningrat
Althea Medical Journal Vol 3, No 1 (2016)
Publisher : Faculty of Medicine Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (539.363 KB)

Abstract

Background: Trabeculectomy is a surgical therapy for glaucoma to preserve visual function by lowering intraocular pressure (IOP). In some studies, the success of trabeculectomy in lowering IOP is greater than medication. Success is defined by IOP <21 mmHg, with or without glaucoma medication. Primary glaucoma based on the mechanism of aquous humor outflow is divided into primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). This study aimed to know the success rate of trabeculectomy in POAG and PACG.Methods: This study was a descriptive study conducted at Cicendo Eye Hospital using medical record of POAG and PACG patients who underwent trabeculectomy surgery on January–December 2013 with minimal one month follow-up. Data collection was conducted during September 2014. Data processed in this study were 100 eyes from 76 patients with diagnosis POAG and PACG.Results: The success rate for trabeculectomy in POAG was 79% and PACG was 86%, failure (IOP ≥ 21 mmHg) 21% in POAG, and 14% in PACG for period 2013 at Cicendo Eye Hospital.Conclusions: The success rate of trabeculectomy at Cicendo Eye Hospital is good in one month, with or without glaucoma medication after surgery. [AMJ.2016;3(1):110–4] DOI: 10.15850/amj.v3n1.723
MANAGEMENT OF SECONDARY ANGLE-CLOSURE GLAUCOMA IN ANTERIOR SEGMENT DYSGENESIS AND ANTERIOR MICROPHTHALMOS PATIENT syifa rahmani; Maula Rifada
Majalah Oftalmologi Indonesia Vol 49 No 2 (2023): Ophthalmologica Indonesiana
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/journal.v49i2.100770

Abstract

Introduction: The majority of cases of anterior segment dysgenesis (ASD) and anterior microphthalmia are known to be complicated by angle-closure glaucoma, which is also the primary cause of visual loss. Medical therapy of this secondary glaucoma is frequently ineffective, necessitating surgery. However, managing the surgery in an eye with a crowded anterior chamber is difficult. This study aimed to report the management of secondary angle-closure glaucoma in anterior segment dysgenesis and anterior micropthalmos patient. Case Report: :  A  39-year-old  woman  presented  to  Glaucoma  unit  with  chief complaint  of  pain  on  the  right  eye.  She  also  noted  blurred  vision,  redness,  and headache  approximately  seven  months  before  presentation.  The  patient  had  a history of glaucoma since 5 years old, but hadn’t regularly visit for a long time. The  visual  acuity  was  1/60  and  intraocular  pressure  (IOP)  was  45.  Anterior segment   evaluation   revealed   scleral   thinning   with   injection,   microcornea, sclerocornea,  hazy  peripheral  cornea,  iridocorneal  adhesion,  shallow  anterior chamber, iris transillumination defect and lens opacity. A-scan biometry showed normal axial length. She was diagnosed with secondary angle-closure glaucoma with anterior segment dysgenesis, anterior microphthalmia and presenile cataract of the right eye. The patient underwent combined phacotrabeculectomy, pars plana vitrectomy and intraocular lens implantation. Discussion: Surgical procedure is indicated if pharmacological therapy cannot control IOP and glaucoma progressivity, including trabeculectomy combined with cataract extraction. However, cataract extraction is more difficult in shallow anterior eye chamber because the working field is narrower and the distance between the cornea and lens is closer. Some strategies to prevent this include pars plana vitrectomy (VPP). Conclusion: Anterior  segment  dysgenesis,  though  rare,  cause  vision  loss  by glaucoma as complication. Treatment of secondary glaucoma aim to lowering IOP to halt its progression. Combined phacotrabeculectomy, pars plana vitrectomy and intraocular  lens  implantation  was  a  safe  procedure  in  this  crowded  anterior chamber eye.
REDUCTION OF INTRAOCULAR PRESSURE POST MICRO PULSE TRANSSCLERAL CYCLOPHOTOCOAGULATION IN REFRACTORY GLAUCOMA PATIENTS: Oral Presentation - Observational Study - Resident Annisa Rahayu; Elsa Gustianty; Andrew M.H Knoch; Maula Rifada; Sonie Umbara
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/tyq5vs98

Abstract

Introduction & ObjectivesCyclodestructive laser is one of the last resource managements for refractory glaucoma, especiallywith low visual potential. Conventional laser using CW-TSCPC showed unstable IOP reduction withcollateral tissue damage. MP-TSCPC using on and off cyclic waves is considered to have a gooddegree of IOP reduction and fewer complications. The purpose of this study is to assess the IOPreduction after the MP-TSCPC procedures for patients with refractory glaucoma. MethodsThis is a prospective observational study for refractory glaucoma patients treated with the MPTSCPClaser procedure. Measurement of IOP was carried out preoperatively and on postoperativedays 1, 7, and 30 with the gold standard Goldmann applanation tonometry. ResultsA total of 33 eyes from 33 patients were enrolled in this study. The mean baseline IOP was 48.45 ±12,79 mmHg. The mean degree of IOP reduction on follow-up days 1, 7, and 30 were 14.39 ±23.52%, 45,83 ± 24,80 and 27.09 ± 23.86% respectively. On the 30th day after the laser treatment,no complications were observed. The number of anti-glaucoma medication was reduced from 2.39 ±0.49 at the baseline to 1.91 ± 0.58 at one month follow up. ConclusionMicro-pulse transscleral cyclophotocoagulation laser showed a good degree of IOP reduction with noincidence of complication observed at day 30.
Co-Authors Andrew M.H Knoch Annisa Rahayu Elsa Gustianty Erva Monica Saputro RB. Soeherman Herdiningrat Sonie Umbara syifa rahmani